Sirona Biochem Corp Total Liabilities

Latest as of July 2024: CA$4.27 Million CAD ≈ $3.09 Million USD

Sirona Biochem Corp total liabilities. Based on the latest financial reports, Sirona Biochem Corp (SBM) has total liabilities worth CA$4.27 Million CAD (≈ $3.09 Million USD) as of July 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SBM financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sirona Biochem Corp (2011–2023)

Total liabilities of Sirona Biochem Corp from 2011 to 2023. This chart illustrates how Sirona Biochem Corp's total liabilities have evolved over time, based on quarterly financial data.

Sirona Biochem Corp Competitors by Total Liabilities

The table below lists competitors of Sirona Biochem Corp ranked by their total liabilities.

Company Country Total Liabilities
Bayhorse Silver Inc
V:BHS
Canada CA$2.49 Million
Legend Power Systems Inc
V:LPS
Canada CA$1.53 Million
Dycasa SA
BA:DYCA
Argentina AR$23.74 Billion
Reach Resources Ltd
AU:RR1
Australia AU$471.57K
InnSuites Hospitality Trust
NYSE MKT:IHT
USA $14.04 Million
AUGA GROUP AB EO 029
F:W9Z
Germany €172.99 Million
Dromeas SA
AT:DROME
Greece €37.44 Million
SKK Holdings Limited
NASDAQ:SKK
USA $24.40 Million

Liability Composition Analysis (2011–2023)

This chart breaks down Sirona Biochem Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Sirona Biochem Corp.

Liquidity & Leverage Metrics

Sirona Biochem Corp Total Liabilities Ratios Explained

Sirona Biochem Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 5.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirona Biochem Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirona Biochem Corp (2011–2023)

The table below shows the annual total liabilities of Sirona Biochem Corp from 2011 to 2023.

Year Total Liabilities Change
2023-10-31 CA$3.54 Million
≈ $2.56 Million
+229.26%
2022-10-31 CA$1.08 Million
≈ $778.50K
-22.27%
2021-10-31 CA$1.38 Million
≈ $1.00 Million
-33.75%
2020-10-31 CA$2.09 Million
≈ $1.51 Million
+1.09%
2019-10-31 CA$2.07 Million
≈ $1.50 Million
-31.80%
2018-10-31 CA$3.03 Million
≈ $2.19 Million
-7.90%
2017-10-31 CA$3.29 Million
≈ $2.38 Million
+110.75%
2016-10-31 CA$1.56 Million
≈ $1.13 Million
-21.95%
2015-10-31 CA$2.00 Million
≈ $1.45 Million
+22.20%
2014-10-31 CA$1.64 Million
≈ $1.18 Million
+36.84%
2013-10-31 CA$1.20 Million
≈ $865.73K
+22.51%
2012-10-31 CA$976.91K
≈ $706.69K
+33.42%
2011-10-31 CA$732.20K
≈ $529.66K
--

About Sirona Biochem Corp

V:SBM Canada Biotechnology
Market Cap
$11.23 Million
CA$15.53 Million CAD
Market Cap Rank
#26653 Global
#1076 in Canada
Share Price
CA$0.06
Change (1 day)
+0.00%
52-Week Range
CA$0.06 - CA$0.06
All Time High
CA$0.66
About

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more